Influenza vaccination and mortality: Differentiating vaccine effects from bias

American Journal of Epidemiology

Volumn 170, Issue 5, 2009, Pages 650-656

  Fireman, Bruce ^a   Lee, Janelle ^a   Lewis, Ned ^a   Bembom, Oliver ^b   Van Der Laan, Mark ^b   Baxter, Roger ^a  

^a DIVISION OF RESEARCH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aged; Epidemiologic methods; Influenza vaccines; Influenza, human; Mortality; Selection bias

Indexed keywords

INFLUENZA VACCINE;

ELDERLY POPULATION; EPIDEMIOLOGY; HEALTH SERVICES; HEALTH SURVEY; INFLUENZA; MORTALITY; PUBLIC HEALTH; REGRESSION ANALYSIS; VACCINATION;

AGED; ARTICLE; DEATH; DRUG EFFICACY; FEMALE; GERIATRICS; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; MAJOR CLINICAL STUDY; MALE; MORTALITY; SEASON; UNITED STATES; AGE; COHORT ANALYSIS; EPIDEMIOLOGY; HEALTH STATUS; RETROSPECTIVE STUDY; RISK ASSESSMENT; UTILIZATION REVIEW; VACCINATION;

CALIFORNIA; NORTH AMERICA; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; CALIFORNIA; COHORT STUDIES; FEMALE; HEALTH STATUS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SELECTION BIAS; VACCINATION;

EID: 70249110808     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp173     Document Type: Article

References (24)

1. Nelson JC, Jackson ML, Weiss NS, et al. New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol. 2009; 62(7):687-694.
2. Nichol KL. Influenza vaccination in the elderly: impact on hospitalization and mortality. Drugs Aging. 2005;22(6): 495-515.
3. Nichol KL, Margolis KL, Wuorenma J, et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994; 331(12):778-784.
4. Nichol KL, Treanor JJ. Vaccines for seasonal and pandemic influenza. J Infect Dis. 2006;194(suppl 2):S111-S118.
5. Vu T, Farish S, Jenkins M, et al. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine. 2002;20(13-14): 1831-1836.
6. Voordouw BC, van der Linden PD, Simonian S, et al. Influenza vaccination in community-dwelling elderly: impact on mortality and influenza-associated morbidity. Arch Intern Med. 2003;163(9):1089-1094.
7. Armstrong BG, Mangtani P, Fletcher A, et al. Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza: cohort study in elderly people. BMJ. 2004;329(7467):660.
8. Jackson LA. Benefits of examining influenza vaccine associations outside of influenza season. Am J Respir Crit Care Med. 2008;178(5):439-440.
9. Jackson LA, Jackson ML, Nelson JC, et al. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol. 2006;35(2):337-344.
10. Jackson LA, Nelson JC, Benson P, et al. Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol. 2006;35(2): 345-352.
11. Simonsen L, Reichert TA, Viboud C, et al. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med. 2005;165(3):265-272.
12. Simonsen L, Taylor RJ, Viboud C, et al. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis. 2007;7(10):658-666.
13. Simonsen L, Viboud C, Taylor RJ. Effectiveness of influenza vaccination [letter]. N Engl J Med. 2007;357(26):2729-2730.
14. Ortqvist A, Granath F, Askling J, et al. Influenza vaccination and mortality: prospective cohort study of the elderly in a large geographical area. Eur Respir J. 2007;30(3):414-422.
15. Jackson ML, Nelson JC, Weiss NS, et al. Influenza vaccination and risk of community-acquired pneumonia in immunocom-petent elderly people: a population-based, nested case-control study. Lancet. 2008;372(9636):398-405.
16. Angrist JD, Pischke JS. Mostly Harmless Econometrics: An Empiricist's Companion. Princeton, NJ: Princeton University Press; 2008:227-243.
17. Zhao Y, Ash AS, Ellis RP, et al. Predicting pharmacy costs and other medical costs using diagnoses and drug claims. Med Care. 2005;43(1):34-43.
18. Zhao Y, Ellis RP, Ash AS, et al. Measuring population health risks using inpatient diagnoses and outpatient pharmacy data. Health Serv Res. 2001;36(6):180-193.
19. Nichol KL, Nordin JD, Nelson DB, et al. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med. 2007;357(14):1373-1381.
20. Simonsen L, Clarke MJ, Stroup DF, et al. A method for timely assessment of influenza-associated mortality in the United States. Epidemiology. 1997;8(4):390-395.
21. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179-186. (Pubitemid 36068705)
22. Simonsen L, Blackwelder WC, Reichert TA, et al. Estimating deaths due to influenza and respiratory syncytial virus [letter]. JAMA. 2003;289(19):2499- 2500.
23. Monto AS. Epidemiology of influenza. Vaccine. 2008; 26(suppl 4):D45-D48.
24. Nichol KL, Nordin J, Mullooly J, et al. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med. 2003;348(14):1322-1332.